Pfizer Wins OK For $75M Deal In Shareholder Suits

A federal judge has given an initial blessing to Pfizer Inc.'s proposed $75 million settlement to end a slew of derivative suits lodged against the drugmaker's executives over a marketing campaign...

Already a subscriber? Click here to view full article